Literature DB >> 7783258

[Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].

H B Guo1, B Stoffel-Wagner, W Brennemann, W Springer, D Klingmüller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783258     DOI: 10.1007/bf02887879

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


× No keyword cloud information.
  13 in total

1.  Determination and characterization of neuron specific protein (NSP) associated enolase activity.

Authors:  P J Marangos; C Zomzely-Neurath; C York
Journal:  Biochem Biophys Res Commun       Date:  1976-02-23       Impact factor: 3.575

Review 2.  Cutaneous melanoma.

Authors:  H K Koh
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

3.  Neuron-specific enolase--a serum marker for malignant melanoma.

Authors:  J Lorenz; W Dippold
Journal:  J Natl Cancer Inst       Date:  1989-11-15       Impact factor: 13.506

4.  Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.

Authors:  P M Zeltzer; P J Marangos; A E Evans; S L Schneider
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

5.  Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.

Authors:  W Fischbach; C Schwarz-Wallrauch; B Jany
Journal:  Cancer       Date:  1989-03-15       Impact factor: 6.860

6.  Neuron specific enolase (NSE) in serum of patients with malignant melanoma.

Authors:  E Wibe; E Paus; S Aamdal
Journal:  Cancer Lett       Date:  1990-06-30       Impact factor: 8.679

7.  Neuron-specific enolase is produced by neuroendocrine tumours.

Authors:  F J Tapia; J M Polak; A J Barbosa; S R Bloom; P J Marangos; C Dermody; A G Pearse
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

8.  Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.

Authors:  E Wibe; E Hannisdal; E Paus; S Aamdal
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

9.  [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].

Authors:  M Uerlich; H Biltz; H W Kreysel
Journal:  Immun Infekt       Date:  1988-04

10.  The prognostic influence of serum neuron specific enolase in small cell lung cancer.

Authors:  L G Jørgensen; K Osterlind; H H Hansen; E H Cooper
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.